AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35195553 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation (preoperative marking and preoperative education with introduction of the patient to the stoma appliance preoperatively and postoperative education)
Number of subjects: 240
Study 35195553 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation
Number of subjects: 240
Study 35195553 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation (temporary stoma patients)
Number of subjects: 240
Study 35195553 — intervention group
Group type: COMPARATOR
Intervention: Control groups A and B (preoperative stoma marking, postoperative education; preoperative marking and preoperative and postoperative education)
Number of subjects: 240
Study 35195553 — intervention group
Group type: COMPARATOR
Intervention: Control groups (permanent stoma patients)
Number of subjects: 240
Study 34103095 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-nasal evaporative cooling during CPR
Number of subjects: 851
Study 34103095 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cooling)
Number of subjects: 851
Study 32006613 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive advance care planning intervention
Number of subjects: 460
Study 32006613 — intervention group
Group type: COMPARATOR
Intervention: Control (symptom management education)
Number of subjects: 460
Study 616084119 — intervention group
Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 20
Study 616084119 — intervention group
Group type: EXPERIMENTAL
Intervention: Femto LASIK
Number of subjects: 20
Study 32491923 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal 200 mcg misoprostol
Number of subjects: 90
Study 32491923 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal 20 mg hyoscine‐n‐butyl bromide
Number of subjects: 90
Study 32491923 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 90
Study 35201305 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced content
Number of subjects: 7153
Study 35201305 — intervention group
Group type: COMPARATOR
Intervention: Standard content
Number of subjects: 7153
Study 35201305 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced support
Number of subjects: 7153
Study 35201305 — intervention group
Group type: COMPARATOR
Intervention: Standard support
Number of subjects: 7153
Study 35201305 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced content (hematological)
Number of subjects: 7153
Study 35201305 — intervention group
Group type: COMPARATOR
Intervention: Standard content (hematological)
Number of subjects: 7153
Study 35201305 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced support (hematological)
Number of subjects: 7153
Study 35201305 — intervention group
Group type: COMPARATOR
Intervention: Standard support (hematological)
Number of subjects: 7153
Study 32570480 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious game (DoBrain)
Number of subjects: 119
Study 32570480 — intervention group
Group type: COMPARATOR
Intervention: NPTs
Number of subjects: 119
Study 36235870 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week multi-strategy behavioral intervention including vegetable provisioning and online menu architecture
Number of subjects: 4302
Study 36235870 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week multi-strategy behavioral intervention
Number of subjects: 4302
Study 36235870 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular canteen menu)
Number of subjects: 4302
Study 35586638 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 1.5% Adrenaline
Number of subjects: 38
Study 35586638 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.5%
Number of subjects: 38
Study 32056820 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute music therapy during colonoscopy
Number of subjects: 112
Study 32056820 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care (control group)
Number of subjects: 112
Study 35617767 — intervention group
Group type: EXPERIMENTAL
Intervention: Purple packaging
Number of subjects: 1063
Study 35617767 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural leaf descriptor
Number of subjects: 1063
Study 35617767 — intervention group
Group type: EXPERIMENTAL
Intervention: Grey packs with natural leaf descriptor
Number of subjects: 1063
Study 32933124 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity cold air exercise at 0 C
Number of subjects: 18
Study 32933124 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity cold air exercise at -20 C
Number of subjects: 18
Study 32933124 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-exertion respiratory function recovery and reported symptoms
Number of subjects: 18
Study 35120199 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin (two doses)
Number of subjects: 4327
Study 35120199 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 4327
Study 35120199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4327
Study 32343445 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise intervention resulting in 10% weight loss
Number of subjects: 125
Study 32343445 — intervention group
Group type: COMPARATOR
Intervention: Diet-only intervention
Number of subjects: 125
Study 32343445 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet combined with exercise intervention
Number of subjects: 125
Study 34410487 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral triple osteotomies + Septoplasty
Number of subjects: 40
Study 34410487 — intervention group
Group type: COMPARATOR
Intervention: Bilateral triple osteotomies + Spreader grafts + Septoplasty
Number of subjects: 40
Study 34261527 — intervention group
Group type: EXPERIMENTAL
Intervention: PolyPrime intervention (online video and patient recall process)
Number of subjects: 12
Study 34261527 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 12
Study 35262569 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 800 mg on day 1 and 400 mg from day 2 to day 7
Number of subjects: 0
Study 35262569 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35381848 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL rapeseed oil per day (RO)
Number of subjects: 84
Study 35381848 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL sunflower oil per day (SO)
Number of subjects: 84
Study 35381848 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet (CON)
Number of subjects: 84
Study 33010974 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 50,000 IU per week for 12 weeks
Number of subjects: 60
Study 33010974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34812074 — intervention group
Group type: EXPERIMENTAL
Intervention: PICC
Number of subjects: 80
Study 34812074 — intervention group
Group type: COMPARATOR
Intervention: Control (peripheral venous access)
Number of subjects: 80
Study 33059911 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g PNO‐FFA (delivered in delayed-release capsules)
Number of subjects: 18
Study 33059911 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g PNO‐FFA (delivered in delayed-release capsules)
Number of subjects: 18
Study 33059911 — intervention group
Group type: COMPARATOR
Intervention: 3 g unhydrolyzed pine nut oil (PNO‐TG)
Number of subjects: 18
Study 33059911 — intervention group
Group type: COMPARATOR
Intervention: No oil
Number of subjects: 18
Study 32127178 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonopioid-based analgesia (acetaminophen and ibuprofen)
Number of subjects: 95
Study 32127178 — intervention group
Group type: COMPARATOR
Intervention: Opioid-based analgesia
Number of subjects: 95
Study 34756698 — intervention group
Group type: EXPERIMENTAL
Intervention: Manchester applicator
Number of subjects: 30
Study 34756698 — intervention group
Group type: COMPARATOR
Intervention: FSD applicator
Number of subjects: 30
Study 33131164 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D3 (2000 IU/day)
Number of subjects: 197
Study 33131164 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (1 g/day)
Number of subjects: 197
Study 34109697 — intervention group
Group type: EXPERIMENTAL
Intervention: 10‐mg ulipristal acetate (UPA) once daily for three 12‐week courses
Number of subjects: 155
Study 32681739 — intervention group
Group type: EXPERIMENTAL
Intervention: Decitabine 10 mg/m2 daily for 10 days plus dasatinib 100 mg daily
Number of subjects: 30
Study 32681739 — intervention group
Group type: EXPERIMENTAL
Intervention: Decitabine 20 mg/m2 daily for 10 days plus dasatinib 100 mg daily
Number of subjects: 30
Study 32681739 — intervention group
Group type: EXPERIMENTAL
Intervention: Decitabine 10 mg/m2 or 20 mg/m2 daily for 10 days plus dasatinib 140 mg daily (target dose)
Number of subjects: 30
Study 35699737 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative Sp o2 target of 88-92%
Number of subjects: 0
Study 35699737 — intervention group
Group type: COMPARATOR
Intervention: Liberal Sp o2 target of more than 94%
Number of subjects: 0
Study 34309124 — intervention group
Group type: EXPERIMENTAL
Intervention: Newborn exome sequencing trial participation
Number of subjects: 82
Study 34309124 — intervention group
Group type: COMPARATOR
Intervention: Control arm of the trial
Number of subjects: 82
Study 32450857 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail group (postal mail outreach)
Number of subjects: 29145
Study 32450857 — intervention group
Group type: COMPARATOR
Intervention: Email group (email outreach)
Number of subjects: 29145
Study 32450857 — intervention group
Group type: EXPERIMENTAL
Intervention: Registered members
Number of subjects: 29145
Study 35879701 — intervention group
Group type: EXPERIMENTAL
Intervention: NP-led care
Number of subjects: 248
Study 35879701 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 248
Study 32628030 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal financial incentives
Number of subjects: 450
Study 32628030 — intervention group
Group type: EXPERIMENTAL
Intervention: Charity financial incentives
Number of subjects: 450
Study 32628030 — intervention group
Group type: COMPARATOR
Intervention: No-incentive control group
Number of subjects: 450
Study 32628030 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice financial incentives
Number of subjects: 450
Study 32628030 — intervention group
Group type: EXPERIMENTAL
Intervention: Loved one financial incentives
Number of subjects: 450
Study 32628030 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-incentivized period
Number of subjects: 450
Study 32741619 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular Smarter Pregnancy program (intervention group)
Number of subjects: 626
Study 32741619 — intervention group
Group type: COMPARATOR
Intervention: Light Smarter Pregnancy program (control group)
Number of subjects: 626
Study 35276064 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine plus amodiaquine
Number of subjects: 310
Study 35276064 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine alone
Number of subjects: 310
Study 33503302 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-component single-pill combination (olmesartan/amlodipine/hydrochlorothiazide 20/5/12.5 mg)
Number of subjects: 145
Study 33503302 — intervention group
Group type: COMPARATOR
Intervention: Equivalent two-pill regimen (olmesartan/hydrochlorothiazide 20/12.5 mg + amlodipine 5 mg)
Number of subjects: 145
Study 32383634 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Number of subjects: 60
Study 32383634 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft ankle orthosis
Number of subjects: 60
Study 32383634 — intervention group
Group type: EXPERIMENTAL
Intervention: Semirigid ankle orthosis
Number of subjects: 60
Study 32383634 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 60
Study 34733500 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritionally complete meal replacement plan (MRP)
Number of subjects: 83
Study 34733500 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 83
Study 34733500 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 83
Study 33779417 — intervention group
Group type: EXPERIMENTAL
Intervention: Three standardized educative phone calls
Number of subjects: 130
Study 33779417 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 130
Study 36222618 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 gram of Tranexamic Acid (TXA) after induction
Number of subjects: 110
Study 36222618 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 110
Study 34103028 — intervention group
Group type: EXPERIMENTAL
Intervention: Proper sitting postures (42%)
Number of subjects: 673
Study 34103028 — intervention group
Group type: EXPERIMENTAL
Intervention: Backpack carrying behaviors (33%)
Number of subjects: 673
Study 33272946 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg folic acid
Number of subjects: 331
Study 33272946 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.8 mg folic acid
Number of subjects: 331
Study 33272946 — intervention group
Group type: COMPARATOR
Intervention: 0 mg folic acid
Number of subjects: 331
Study 34718943 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal cerebellar transcranial direct current stimulation (tDCS) for 20 min at 2 mA
Number of subjects: 20
Study 34718943 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal cerebellar transcranial direct current stimulation (tDCS) for 20 min at 2 mA
Number of subjects: 20
Study 34718943 — intervention group
Group type: COMPARATOR
Intervention: Sham cerebellar transcranial direct current stimulation (tDCS)
Number of subjects: 20
Study 34962559 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (120,000 IU of cholecalciferol monthly)
Number of subjects: 149
Study 34962559 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 149
Study 34811502 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline circulating tumour DNA (ctDNA) variant allele fraction (VAF)
Number of subjects: 135
Study 33725270 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmydriatic ultra‐wide‐field scanning laser ophthalmoscope (SLO) (Optos Daytona)
Number of subjects: 101
Study 32037556 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based survey assessing willingness to donate tissues for regenerative therapy
Number of subjects: 1118
Study 32037556 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased familiarity with regenerative medicine through a brief paragraph of information
Number of subjects: 1118
Study 32037556 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for nonprofit groups in research and development
Number of subjects: 1118
Study 32037556 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors influencing donor willingness
Number of subjects: 1118
Study 32037556 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to donate blood
Number of subjects: 1118
Study 34482306 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized sound therapy with tinnitus sound matching (group A)
Number of subjects: 100
Study 34482306 — intervention group
Group type: COMPARATOR
Intervention: Customized sound therapy without tinnitus sound matching (group B)
Number of subjects: 100
Study 32001493 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (physiotherapist-led aerobic and resistance exercise including behaviour change techniques)
Number of subjects: 0
Study 32001493 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 34610129 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Milk (WM)
Number of subjects: 22
Study 34610129 — intervention group
Group type: EXPERIMENTAL
Intervention: Skim Milk (SM)
Number of subjects: 22
Study 34610129 — intervention group
Group type: EXPERIMENTAL
Intervention: Almond Beverage (AB)
Number of subjects: 22
Study 34610129 — intervention group
Group type: COMPARATOR
Intervention: Phase 1 to Phase 2 (Diet Intervention)
Number of subjects: 22
Study 34610129 — intervention group
Group type: COMPARATOR
Intervention: Phase 2 to Phase 3 (Intervention Diet + PA)
Number of subjects: 22
Study 32045406 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolotherapy (PrT) injections
Number of subjects: 41
Study 32045406 — intervention group
Group type: COMPARATOR
Intervention: Exercise (control group)
Number of subjects: 41
Study 36350379 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐enabled lifestyle intervention (Women's Wellness after Cancer Program)
Number of subjects: 351
Study 36350379 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 351
Study 34880957 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanshinone IIA (TSN)
Number of subjects: 100
Study 34880957 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 100
Study 32458107 — intervention group
Group type: EXPERIMENTAL
Intervention: e-APA (web-based adapted physical activity program)
Number of subjects: 63
Study 32458107 — intervention group
Group type: COMPARATOR
Intervention: e-HE (health education program)
Number of subjects: 63
Study 32558178 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 410
Study 32558178 — intervention group
Group type: COMPARATOR
Intervention: Thulium laser transurethral vaporesection of the prostate (ThuVARP)
Number of subjects: 410
Study 32558178 — intervention group
Group type: EXPERIMENTAL
Intervention: TURP
Number of subjects: 410
Study 32558178 — intervention group
Group type: COMPARATOR
Intervention: ThuVARP
Number of subjects: 410
Study 32021173 — intervention group
Group type: EXPERIMENTAL
Intervention: NSB drug capsules along with the standard of care treatment (Arm B)
Number of subjects: 0
Study 32021173 — intervention group
Group type: COMPARATOR
Intervention: Standard of care treatment (Arm A)
Number of subjects: 0
Study 35986934 — intervention group
Group type: EXPERIMENTAL
Intervention: Home bleaching with 16% carbamide peroxide (CP) and restriction of colored foods without red wine mouthwash
Number of subjects: 45
Study 35986934 — intervention group
Group type: COMPARATOR
Intervention: Home bleaching with 16% carbamide peroxide (CP) with colored foods and red wine mouthwash
Number of subjects: 45
Study 35986934 — intervention group
Group type: COMPARATOR
Intervention: Home bleaching with 16% carbamide peroxide (CP) with colored foods without red wine mouthwash
Number of subjects: 45
Study 34090214 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal education concerning nutrition, hygiene, and child stimulation for 6 months.
Number of subjects: 511
Study 34090214 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 511
Study 35484744 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 0
Study 35484744 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-106a nanoparticles (NPs)
Number of subjects: 0
Study 35484744 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) and miR-106a nanoparticles (NPs)
Number of subjects: 0
Study 35484744 — intervention group
Group type: COMPARATOR
Intervention: Ischemic reperfusion (IR) set
Number of subjects: 0
Study 35484744 — intervention group
Group type: COMPARATOR
Intervention: Control set
Number of subjects: 0
Study 35092666 — intervention group
Group type: COMPARATOR
Intervention: 3LP repair alone
Number of subjects: 24
Study 35092666 — intervention group
Group type: COMPARATOR
Intervention: 3VCP
Number of subjects: 24
Study 35092666 — intervention group
Group type: EXPERIMENTAL
Intervention: 5VCP
Number of subjects: 24
Study 35092666 — intervention group
Group type: EXPERIMENTAL
Intervention: 7VCP
Number of subjects: 24
Study 35092666 — intervention group
Group type: EXPERIMENTAL
Intervention: 5VCP and 7VCP
Number of subjects: 24
Study 32899089 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser therapy
Number of subjects: 35
Study 32899089 — intervention group
Group type: COMPARATOR
Intervention: Sham laser (control)
Number of subjects: 35
Study 32899089 — intervention group
Group type: EXPERIMENTAL
Intervention: Between-group comparison
Number of subjects: 35
Study 36251378 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized behavioral intervention to reduce daily sedentary behavior by 1 hour
Number of subjects: 64
Study 36251378 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 64
Study 36251378 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized behavioral intervention
Number of subjects: 64
Study 33201262 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0
Study 33201262 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 0
Study 33201262 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 0
Study 33201262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35789164 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical calcipotriol (0.005%) cream
Number of subjects: 40
Study 35789164 — intervention group
Group type: COMPARATOR
Intervention: 0.1% adapalene gel
Number of subjects: 40
Study 32826000 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomechanical Taping
Number of subjects: 68
Study 32826000 — intervention group
Group type: COMPARATOR
Intervention: Kinesio Taping
Number of subjects: 68
Study 33973806 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferulic acid (200 mg)
Number of subjects: 16
Study 33973806 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 34315990 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 466
Study 34315990 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicametate
Number of subjects: 466
Study 32295092 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5 g of fructooligosaccharides + 2 g of maltodextrin (FOS group)
Number of subjects: 53
Study 32295092 — intervention group
Group type: COMPARATOR
Intervention: 2 g of maltodextrin (placebo group)
Number of subjects: 53
Study 32295092 — intervention group
Group type: EXPERIMENTAL
Intervention: FOS supplementation
Number of subjects: 53
Study 36446689 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral TAPB
Number of subjects: 70
Study 36446689 — intervention group
Group type: COMPARATOR
Intervention: CEB
Number of subjects: 70
Study 33574076 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily
Number of subjects: 209